Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

Research output: Contribution to journal › Editorial

Access to Document

@article{859cba22a02243c384fa0fd814e43327,

title = "Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma",

author = "Lee, {Ji Yeon} and Sung, {Pil Soo}",

year = "2024",

month = jul,

doi = "10.5009/gnl240274",

language = "English",

volume = "18",

pages = "558--559",

journal = "Gut and Liver",

issn = "1976-2283",

publisher = "Joe Bok Chung",

number = "4",

}

TY - JOUR

T1 - Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

AU - Lee, Ji Yeon

AU - Sung, Pil Soo

PY - 2024/7

Y1 - 2024/7

UR - http://www.scopus.com/inward/record.url?scp=85199015696&partnerID=8YFLogxK

U2 - 10.5009/gnl240274

DO - 10.5009/gnl240274

M3 - Editorial

C2 - 39005198

AN - SCOPUS:85199015696

SN - 1976-2283

VL - 18

SP - 558

EP - 559

JO - Gut and Liver

JF - Gut and Liver

IS - 4

ER -